de Haas Ellen R M, de Bruijn Henriette S, Sterenborg Henricus J C M, Neumann H A Martino, Robinson Dominic J
Department of Dermatology, Erasmus MC Rotterdam, The Netherlands.
Acta Derm Venereol. 2008;88(6):547-54. doi: 10.2340/00015555-0508.
Light fractionation in aminolaevulinic acid photodynamic therapy (PDT) of superficial basal cell carcinoma has been shown to enhance the therapeutic efficacy significantly. We have shown previously that this increase in efficacy is not simply due to an increase in the amount of protoporphyrin utilized during therapy. The present study investigated the spatial distribution of protoporphyrin in 32 superficial basal cell carcinomas undergoing light-fractionated PDT. Superficial fluorescence imaging performed during therapy was compared with the microscopic analysis of protoporphyrin fluorescence in biopsies acquired immediately before the second of two light fractions. The microscopic distribution of fluorescence was also compared with tumour sections immunohistochemically stained for Ki-67. Large variations in superficial and microscopic protoporphyrin fluorescence were found in both control and treated lesions. Despite these variations there was a reasonable correlation between the two techniques (R2=0.86). The mean fluorescence intensity in control biopsies was greater than in illuminated lesions before the second light fraction, but there was no significant difference in the variation within and between regions of interest in each of these sets of lesions. There was no clear trend in depth of protoporphyrin reappearance during the dark interval between light fractions. The general distribution of cells stained positive for Ki-67 followed the protoporphyrin fluorescence that was associated with islands of basal cell carcinoma. In conclusion, this study confirms that the mean relative re-synthesis of protoporphyrin after PDT is consistent with that found previously in pre-clinical models. There are large variations in fluorescence within superficial basal cell carcinoma that include regions of tumour cells that do not synthesize protoporphyrin.
在浅表性基底细胞癌的氨基乙酰丙酸光动力疗法(PDT)中,分次照射已被证明能显著提高治疗效果。我们之前已经表明,这种疗效的提高不仅仅是由于治疗期间利用的原卟啉量增加。本研究调查了32例接受分次光动力治疗的浅表性基底细胞癌中原卟啉的空间分布。将治疗期间进行的表面荧光成像与在两次光照射中的第二次照射前立即获取的活检组织中原卟啉荧光的显微镜分析进行比较。还将荧光的显微镜分布与免疫组织化学染色检测Ki-67的肿瘤切片进行比较。在对照病变和治疗病变中均发现表面和显微镜下原卟啉荧光存在很大差异。尽管存在这些差异,但两种技术之间仍存在合理的相关性(R2 = 0.86)。对照活检组织中的平均荧光强度在第二次光照射前大于照射病变,但每组病变中感兴趣区域内和区域间的变化没有显著差异。在光照射之间的黑暗间隔期间,原卟啉重新出现的深度没有明显趋势。Ki-67染色阳性细胞的总体分布与与基底细胞癌岛相关的原卟啉荧光一致。总之,本研究证实光动力治疗后原卟啉的平均相对再合成与之前在临床前模型中发现的一致。浅表性基底细胞癌内的荧光存在很大差异,包括不合成原卟啉的肿瘤细胞区域。